Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elizabeth Kunkoski
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
ORCID:
0000-0002-4272-829X
Observed ORCID:
0000-0002-4272-829X
OpenAlex ID:
A5035032655
Digital Health Technology to Measure Drug Efficacy in Clinical Trials for Parkinson’s Disease: A Regulatory Perspective
2021
·
Leonard Sacks
, Elizabeth Kunkoski
·
Journal of Parkinson s Disease
·
35
PDF
FDA Perspective on the Importance of Digital Health Technologies in Clinical Trials
2025
·
Elizabeth Kunkoski
, Anindita Saha
, et al.
·
JAMA Health Forum
·
13
PDF
Digital Health Technologies in Pediatric Trials
2022
·
Leonard Sacks
, Elizabeth Kunkoski
, et al.
·
Therapeutic Innovation & Regulatory Science
·
13
Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials
2022
·
Bohdana Ratitch
, Elizabeth Kunkoski
, et al.
·
Digital Biomarkers
·
10
Emerging clinical pharmacology topics in drug development and precision medicine
2021
·
Qi Liu
, Jack A Gilbert
, et al.
·
Elsevier eBooks
·
3
Landscape Analysis of Digital Health Technology Use for Remote Data Acquisition in CDER ‐Regulated Submissions, 2023–2025
2026
·
Ayoub Suliman
, Norah Xiao
, et al.
·
Clinical and Translational Science
PDF
Show more works
View as search
Works count:
7
Citation count:
74
H-index:
4
I10-index:
4
Year
Topic
Type